Literature DB >> 12959288

Distribution of indomethacin in human milk and estimation of its milk to plasma ratio in vitro.

L Beaulac-Baillargeon1, G Allard.   

Abstract

1. The distribution of indomethacin in fat and protein fractions of colostrum and mature milk as well as its milk to plasma drug concentration ratio (M/P ratio) were determined in vitro. 2. The extent of plasma protein binding of indomethacin (5-20 microg ml(-1)) was > or = 99.6%. The protein binding of indomethacin in colostrum was 46.0% at pH 7.4. The lower protein content of mature milk compared with colostrum was associated with a significant decrease in the extent of drug protein binding (46 +/- 1.93 to 35 +/- 1.0 s.e. mean). Protein binding was also decreased significantly in 8% fat mature milk (20.3 +/- 2.4 s.e mean) but was constant over the pH range 7.4 to 6.8. 3. About 40% of indomethacin added to milk was associated with the fatty layer. The indomethacin M/P ratio determined by equilibrium dialysis was less than 0.01. Hence the maximum infant daily dose was estimated to be 0.006 mg kg(-1). 4. Our results indicate that indomethacin transfers to milk by simple diffusion according to its physicochemical properties, and that treatment with indomethacin is not a contraindication to breast feeding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 12959288      PMCID: PMC1364613          DOI: 10.1111/j.1365-2125.1993.tb00389.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Interaction between salicylic acid and indomethacin in binding to human serum albumin.

Authors:  D Hultmark; K O Borg; R Elofsson; L Palmer
Journal:  Acta Pharm Suec       Date:  1975

2.  Drug binding and solubility in milk.

Authors:  P E Macheras; M A Koupparis; S G Antimisiaris
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

3.  Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat.

Authors:  J C Fleishaker; N Desai; P J McNamara
Journal:  J Pharm Sci       Date:  1987-03       Impact factor: 3.534

4.  Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate, in vitro.

Authors:  R W Mason; E G McQueen
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

5.  Relationship between human milk lipid-ultrafiltrate and octanol-water partition coefficients.

Authors:  H C Atkinson; E J Begg
Journal:  J Pharm Sci       Date:  1988-09       Impact factor: 3.534

Review 6.  Determinants and consequences of drug excretion in breast milk.

Authors:  J T Wilson
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

7.  Creamatocrit: simple clinical technique for estimating fat concentration and energy value of human milk.

Authors:  A Lucas; J A Gibbs; R L Lyster; J D Baum
Journal:  Br Med J       Date:  1978-04-22

8.  Convulsions in a breast-fed infant after maternal indomethacin.

Authors:  O Eeg-Olofsson; I Malmros; C E Elwin; B Steen
Journal:  Lancet       Date:  1978-07-22       Impact factor: 79.321

Review 9.  Antirheumatic medication during lactation.

Authors:  C J Needs; P M Brooks
Journal:  Br J Rheumatol       Date:  1985-08

10.  Pharmacokinetics of indomethacin in the premature infant.

Authors:  G Bianchetti; P Monin; F Marchal; C Dubruc; M J Boutroy; P L Morselli; P Vert
Journal:  Dev Pharmacol Ther       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.